JP2024539141A5 - - Google Patents
Info
- Publication number
- JP2024539141A5 JP2024539141A5 JP2024523627A JP2024523627A JP2024539141A5 JP 2024539141 A5 JP2024539141 A5 JP 2024539141A5 JP 2024523627 A JP2024523627 A JP 2024523627A JP 2024523627 A JP2024523627 A JP 2024523627A JP 2024539141 A5 JP2024539141 A5 JP 2024539141A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- muscular dystrophy
- binding
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163270352P | 2021-10-21 | 2021-10-21 | |
| US63/270,352 | 2021-10-21 | ||
| PCT/US2022/078510 WO2023070087A1 (en) | 2021-10-21 | 2022-10-21 | Compositions and methods for treating muscular dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539141A JP2024539141A (ja) | 2024-10-28 |
| JP2024539141A5 true JP2024539141A5 (https=) | 2025-10-29 |
Family
ID=86059727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523627A Pending JP2024539141A (ja) | 2021-10-21 | 2022-10-21 | 筋ジストロフィーを治療するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250230225A1 (https=) |
| EP (1) | EP4419144A4 (https=) |
| JP (1) | JP2024539141A (https=) |
| CA (1) | CA3235802A1 (https=) |
| WO (1) | WO2023070087A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117174164B (zh) * | 2023-10-30 | 2024-02-13 | 晨伫(杭州)生物科技有限责任公司 | 基于预测蛋白质-小分子结合姿势筛选先导化合物的方法 |
| EP4670793A1 (en) * | 2024-06-24 | 2025-12-31 | Montis Biosciences BV | C1Q ANTIGEN BINDING MOLECULES |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3019240T3 (da) * | 2013-07-09 | 2024-06-03 | Annexon Inc | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf |
-
2022
- 2022-10-21 JP JP2024523627A patent/JP2024539141A/ja active Pending
- 2022-10-21 US US18/703,211 patent/US20250230225A1/en active Pending
- 2022-10-21 EP EP22884725.7A patent/EP4419144A4/en active Pending
- 2022-10-21 WO PCT/US2022/078510 patent/WO2023070087A1/en not_active Ceased
- 2022-10-21 CA CA3235802A patent/CA3235802A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7579227B2 (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| JP2021501134A5 (https=) | ||
| JP2018512379A5 (https=) | ||
| CN116239698A (zh) | 双功能融合蛋白及其医药用途 | |
| JP2024539141A5 (https=) | ||
| JP2021191267A5 (https=) | ||
| JP7471224B2 (ja) | Ｈ因子増強抗体及びその使用 | |
| JP2014509510A5 (https=) | ||
| JP2017534577A5 (https=) | ||
| CN110799543A (zh) | 肝细胞癌的免疫治疗 | |
| JP2024541680A5 (https=) | ||
| JP2019513726A5 (https=) | ||
| JP2023540526A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2022512863A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2024532886A5 (https=) | ||
| JP2022516071A5 (https=) | ||
| JP7377185B2 (ja) | 抗ヒトｔｌｒ７抗体 | |
| JP2022553851A5 (https=) | ||
| JP2024503784A5 (https=) | ||
| JP2023509373A5 (https=) | ||
| CN121399158A (zh) | 用于治疗多发性骨髓瘤的方法 | |
| JPWO2022044573A5 (https=) |